BIB_426
T1 (thin, ≤1.0 mm) melanoma patients have OVERALL survival SIMILAR TO OR BETTER THAN the matched general population — the most powerfully reassuring population-level survival framing available for this patient, AND the BIB388 competing-risk spine proven from the opposite direction: the reason thin-melanoma cohorts match/outlive the population is their LOW competing-disease (CV/dementia/COPD) burden, which tracks high SES. Critical patient-specific inversion: this benefit is earned via low competing-risk burden, not inherited from the diagnosis — and this patient (war refugee, low SES, BMI 30.…
- Evidence grade
- A
- Tier
- 1 (nationwide re
- Cited by tasks
- 22, 22a, 23, 25, 26
- Identifiers
- PMC12996739
↗ Follow the original source for full context
Full extracted findings & patient-implication analysis: bibliography/BIB_426/findings.md (research corpus). This page is a short context summary — not individualised medical advice.